Clinical Trial Update: Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 trial evaluates adding an anti-IL-1α monoclonal antibody to trifluridine/tipiracil vs placebo in metastatic colorectal cancer after failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anti-IL-1α monoclonal antibody
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING